Medplus Q1FY27 revenue rises 21.8%, PAT falls 21.7%
Medplus Health Services reported a 21.8% YoY increase in revenue to ₹18,796 million for Q1FY27, but net profit fell 21.7% to ₹331.7 million due to margin contraction. The retail segment drove revenue, while diagnostics showed strong EBITDA growth. The Board approved ₹1,550 million in capital expenditure plans and appointed a new Company Secretary. The AGM is scheduled for August 17, 2026, with remote e-voting available from August 10, 2026.

*this image is generated using AI for illustrative purposes only.
Medplus Health Services reported a 21.8% year-on-year increase in revenue to ₹18,796 million for the quarter ended June 30, 2026 (Q1FY27). Despite the top-line growth, net profit after tax (PAT) declined by 21.7% to ₹331.7 million, impacted by margin contraction. The Board of Directors approved the unaudited standalone and consolidated financial results on July 21, 2026, along with significant capital expenditure plans totalling ₹1,550 million. Subsequently, the company submitted the audio recording of the earnings call held on July 22, 2026, with analysts and institutional investors to discuss these results.
Financial Performance
The revenue growth was primarily driven by the retail segment, which contributed ₹18,423.92 million. However, the gross margin contracted by 160 basis points year-on-year to 24.5%, attributed to a lower sales mix of private label products and lower margins realized in the franchisee business. The operating EBITDA margin fell to 3.5% from 4.7% in the prior year, while the EBITDA margin stood at 7.1% compared to 8.47% in the corresponding period of the previous year.
| Metric | Q1 FY27 | Q1 FY26 | YoY Change |
|---|---|---|---|
| Revenue | ₹18,796.0 million | ₹15,426.3 million | +21.8% |
| Gross Margin | 24.5% | 26.1% | -160 bps |
| EBITDA | ₹1.33 billion | ₹1.31 billion | — |
| EBITDA Margin | 7.1% | 8.47% | — |
| Operating EBITDA | ₹651.2 million | ₹728.1 million | -10.6% |
| Operating EBITDA Margin | 3.5% | 4.7% | -120 bps |
| PAT | ₹331.7 million | ₹423.5 million | -21.7% |
Segment Performance
The retail segment saw its operating EBITDA drop by 14.8% year-on-year to ₹588.1 million, with margins shrinking to 3.2%. Conversely, the diagnostics segment showed strong growth, with revenue rising 22.4% to ₹370.8 million and operating EBITDA increasing 59.5% to ₹65.9 million.
Strategic Updates
The Board approved a CAPEX plan of approximately ₹400 million for Optival Health Solutions Private Limited, a material subsidiary, to set up a Food Park including a Cold Press Oil Extraction Unit at Hyderabad. Additionally, the company approved an investment of approximately ₹1,150 million to establish a Concierge Health & Wellness Services Facility in Hyderabad, comprising capital expenditure of ₹900 million. The Board also appointed Mr. Shrenik Soni as Company Secretary and Compliance Officer effective July 21, 2026.
Regulatory Filings
The company submitted newspaper clippings of the unaudited financial results published in the Financial Express and Nava Telangana on July 22, 2026, to the BSE and NSE. Furthermore, the Board scheduled the Twentieth Annual General Meeting (AGM) for Monday, August 17, 2026, at 03:30 P.M. via Video Conferencing. Remote e-voting facilities will be available to members as on the cut-off date of August 10, 2026.
Historical Stock Returns for Medplus Health Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.91% | -1.48% | -16.02% | -21.77% | -24.92% | -38.43% |
What is the expected timeline for the new CAPEX projects to become accretive to earnings?
Will the company adjust its pricing strategy to recover the gross margins lost in the franchisee business?
How will the ₹1,550 million capital expenditure impact the company's free cash flow and debt levels in the near term?


































